Company registration number 06673332 (England and Wales)
PHA R&D CENTRE EUROPE LTD
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
PHA R&D CENTRE EUROPE LTD
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 7
PHA R&D CENTRE EUROPE LTD
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
324,107
380,441
Current assets
Stocks
310,652
250,970
Debtors
4
299,325
271,636
Cash at bank and in hand
147,286
398,123
757,263
920,729
Creditors: amounts falling due within one year
5
(266,388)
(311,142)
Net current assets
490,875
609,587
Total assets less current liabilities
814,982
990,028
Creditors: amounts falling due after more than one year
6
-
0
(230,000)
Provisions for liabilities
(53,000)
(65,000)
Net assets
761,982
695,028
Capital and reserves
Called up share capital
7
100
100
Profit and loss reserves
761,882
694,928
Total equity
761,982
695,028

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 4 September 2026 and are signed on its behalf by:
Mr N V Spurr
Director
Company registration number 06673332 (England and Wales)
PHA R&D CENTRE EUROPE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

PHA R&D Centre Europe Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Unit 3 Wharfside, Rounds Green Road, Sandwell Green, Oldbury, West Midlands, B69 2BU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

In the directors' opinion, sufficient support is forthcoming from the company's parent undertaking, Pyeong Hwa Automotive Co Ltd, who have confirmed that it will maintain its financial support until at least 31 December 2027 to enable the company to continue normal trading conditions. The financial statements are, therefore, drawn up on a going concern basis. The financial statements do not include any adjustments that would result from the withdrawal of such support.true

1.3
Turnover

Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
10% and 20% p.a on a straight line basis
Plant and machinery
25% p.a on reducing balance basis
Fixtures, fittings and equipment
20% p.a on reducing balance basis
Computer equipment
33.3% p.a on a straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Stocks

Stock is valued at the lower of cost and net realisable value, with work in progress valued dependent on the stage of completion of work done as at the balance sheet date.

PHA R&D CENTRE EUROPE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans and loans from fellow group companies that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

PHA R&D CENTRE EUROPE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Retirement benefits

The company operates a defined contribution pension scheme for its employees. The assets of the scheme are held separately from those of the company. The annual contributions payable are charged to the profit and loss account.

1.11
Leases

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.12
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

PHA R&D CENTRE EUROPE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
2
Employees

The average monthly number of persons (excluding directors) employed by the company during the year was:

2025
2024
Number
Number
Total
9
10
3
Tangible fixed assets
Leasehold land and buildings
Plant and machinery
Fixtures, fittings and equipment
Computer equipment
Total
£
£
£
£
£
Cost
At 1 January 2025
515,306
67,053
24,365
7,845
614,569
Additions
-
0
-
0
-
0
90
90
At 31 December 2025
515,306
67,053
24,365
7,935
614,659
Depreciation and impairment
At 1 January 2025
150,824
59,802
17,035
6,467
234,128
Depreciation charged in the year
52,245
1,813
1,466
900
56,424
At 31 December 2025
203,069
61,615
18,501
7,367
290,552
Carrying amount
At 31 December 2025
312,237
5,438
5,864
568
324,107
At 31 December 2024
364,482
7,251
7,330
1,378
380,441
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
237,161
187,302
Other debtors
62,164
84,334
299,325
271,636
PHA R&D CENTRE EUROPE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
5
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
30,926
95,067
Amounts owed to group undertakings
120,166
23,295
Corporation tax
36,132
123,744
Other taxation and social security
28,020
3,936
Other creditors
51,144
65,100
266,388
311,142

During the prior year the company received a loan from a group company. This loan has interest charged at 4.6%, is unsecured, with a repayment date of 22 December 2026, although clearance has been made by June 2026.

6
Creditors: amounts falling due after more than one year
2025
2024
£
£
Amounts owed to group undertakings
-
0
230,000
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
8
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
Robert Kempson ACA
Statutory Auditor:
Edwards
Date of audit report:
4 September 2026
PHA R&D CENTRE EUROPE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
9
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
106,240
197,303
10
Related party transactions

The company has taken advantage of the exemption conferred within FRS102 section 33.1A not to disclose transactions between wholly owned members of the same group.

11
Parent company

PHA Co., Ltd., a company registered in South Korea, is the parent company by virtue of a majority shareholding.

Pyeong Hwa Clutch industry Co Ltd, a company registered in South Korea, is the ultimate controlling party.

2025-12-312025-01-01falsefalsefalse04 September 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr N V SpurrMr G S KalsiMr H Sang-BumMr S H HurMr D Y Kim066733322025-01-012025-12-31066733322025-12-31066733322024-12-3106673332core:PlantMachinery2025-12-3106673332core:FurnitureFittings2025-12-3106673332core:ComputerEquipment2025-12-3106673332core:LandBuildings2024-12-3106673332core:PlantMachinery2024-12-3106673332core:FurnitureFittings2024-12-3106673332core:ComputerEquipment2024-12-3106673332core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3106673332core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3106673332core:Non-currentFinancialInstrumentscore:AfterOneYear2025-12-3106673332core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3106673332core:CurrentFinancialInstruments2025-12-3106673332core:CurrentFinancialInstruments2024-12-3106673332core:ShareCapital2025-12-3106673332core:ShareCapital2024-12-3106673332core:RetainedEarningsAccumulatedLosses2025-12-3106673332core:RetainedEarningsAccumulatedLosses2024-12-3106673332core:ShareCapitalOrdinaryShareClass12025-12-3106673332core:ShareCapitalOrdinaryShareClass12024-12-3106673332bus:Director12025-01-012025-12-3106673332core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-01-012025-12-3106673332core:PlantMachinery2025-01-012025-12-3106673332core:FurnitureFittings2025-01-012025-12-3106673332core:ComputerEquipment2025-01-012025-12-31066733322024-01-012024-12-3106673332core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-12-3106673332core:PlantMachinery2024-12-3106673332core:FurnitureFittings2024-12-3106673332core:ComputerEquipment2024-12-31066733322024-12-3106673332core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-12-3106673332core:Non-currentFinancialInstruments2025-12-3106673332core:Non-currentFinancialInstruments2024-12-3106673332bus:OrdinaryShareClass12025-01-012025-12-3106673332bus:OrdinaryShareClass12025-12-3106673332bus:OrdinaryShareClass12024-12-3106673332bus:PrivateLimitedCompanyLtd2025-01-012025-12-3106673332bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3106673332bus:FRS1022025-01-012025-12-3106673332bus:Audited2025-01-012025-12-3106673332bus:Director22025-01-012025-12-3106673332bus:Director32025-01-012025-12-3106673332bus:Director42025-01-012025-12-3106673332bus:Director52025-01-012025-12-3106673332bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP